These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Molecular characterization of fluoroquinolone-resistant Mycobacterium tuberculosis clinical isolates from Shanghai, China. Zhu C; Zhang Y; Shen Y; Siu GK; Wu W; Qian X; Deng G; Xu Y; Lau R; Fan X; Zhang W; Lu H; Yam WC Diagn Microbiol Infect Dis; 2012 Jul; 73(3):260-3. PubMed ID: 22560167 [TBL] [Abstract][Full Text] [Related]
4. Detection of gyrA and gyrB mutations in quinolone-resistant clinical isolates of Escherichia coli by single-strand conformational polymorphism analysis and determination of levels of resistance conferred by two different single gyrA mutations. Ouabdesselam S; Hooper DC; Tankovic J; Soussy CJ Antimicrob Agents Chemother; 1995 Aug; 39(8):1667-70. PubMed ID: 7486897 [TBL] [Abstract][Full Text] [Related]
5. Characterization of fluoroquinolone-resistant mutant strains of Mycobacterium tuberculosis selected in the laboratory and isolated from patients. Alangaden GJ; Manavathu EK; Vakulenko SB; Zvonok NM; Lerner SA Antimicrob Agents Chemother; 1995 Aug; 39(8):1700-3. PubMed ID: 7486904 [TBL] [Abstract][Full Text] [Related]
6. Quinolone resistance mutations in the DNA gyrase gyrA and gyrB genes of Staphylococcus aureus. Ito H; Yoshida H; Bogaki-Shonai M; Niga T; Hattori H; Nakamura S Antimicrob Agents Chemother; 1994 Sep; 38(9):2014-23. PubMed ID: 7811012 [TBL] [Abstract][Full Text] [Related]
7. Ciprofloxacin and the fluoroquinolones. New concepts on the mechanism of action and resistance. Fisher LM; Lawrence JM; Josty IC; Hopewell R; Margerrison EE; Cullen ME Am J Med; 1989 Nov; 87(5A):2S-8S. PubMed ID: 2574005 [TBL] [Abstract][Full Text] [Related]
8. Role of gyrB Mutations in Pre-extensively and Extensively Drug-Resistant Tuberculosis in Thai Clinical Isolates. Disratthakit A; Prammananan T; Tribuddharat C; Thaipisuttikul I; Doi N; Leechawengwongs M; Chaiprasert A Antimicrob Agents Chemother; 2016 Sep; 60(9):5189-97. PubMed ID: 27297489 [TBL] [Abstract][Full Text] [Related]
9. Sequence Analysis of Fluoroquinolone Resistance-Associated Genes gyrA and gyrB in Clinical Mycobacterium tuberculosis Isolates from Patients Suspected of Having Multidrug-Resistant Tuberculosis in New Delhi, India. Singhal R; Reynolds PR; Marola JL; Epperson LE; Arora J; Sarin R; Myneedu VP; Strong M; Salfinger M J Clin Microbiol; 2016 Sep; 54(9):2298-305. PubMed ID: 27335153 [TBL] [Abstract][Full Text] [Related]
10. Characterization of gyrA and gyrB mutations associated with fluoroquinolone resistance in Mycobacterium tuberculosis isolates from Morocco. Chaoui I; Oudghiri A; El Mzibri M J Glob Antimicrob Resist; 2018 Mar; 12():171-174. PubMed ID: 29033301 [TBL] [Abstract][Full Text] [Related]
11. Cloning and nucleotide sequence of the gyrA gene from Campylobacter fetus subsp. fetus ATCC 27374 and characterization of ciprofloxacin-resistant laboratory and clinical isolates. Taylor DE; Chau AS Antimicrob Agents Chemother; 1997 Mar; 41(3):665-71. PubMed ID: 9056011 [TBL] [Abstract][Full Text] [Related]
13. DNA gyrase inhibition assays are necessary to demonstrate fluoroquinolone resistance secondary to gyrB mutations in Mycobacterium tuberculosis. Pantel A; Petrella S; Matrat S; Brossier F; Bastian S; Reitter D; Jarlier V; Mayer C; Aubry A Antimicrob Agents Chemother; 2011 Oct; 55(10):4524-9. PubMed ID: 21768507 [TBL] [Abstract][Full Text] [Related]
14. Analysis of the mechanisms of quinolone resistance in clinical isolates of Citrobacter freundii. Navia MM; Ruiz J; Ribera A; de Anta MT; Vila J J Antimicrob Chemother; 1999 Dec; 44(6):743-8. PubMed ID: 10590274 [TBL] [Abstract][Full Text] [Related]
15. Ciprofloxacin resistance in Campylobacter jejuni isolates: detection of gyrA resistance mutations by mismatch amplification mutation assay PCR and DNA sequence analysis. Zirnstein G; Li Y; Swaminathan B; Angulo F J Clin Microbiol; 1999 Oct; 37(10):3276-80. PubMed ID: 10488192 [TBL] [Abstract][Full Text] [Related]
16. Detection of mutations in the gyrA and parC genes in quinolone-resistant clinical isolates of Enterobacter cloacae. Deguchi T; Yasuda M; Nakano M; Ozeki S; Kanematsu E; Nishino Y; Ishihara S; Kawada Y J Antimicrob Chemother; 1997 Oct; 40(4):543-9. PubMed ID: 9372424 [TBL] [Abstract][Full Text] [Related]
17. Comparative studies of mutations in animal isolates and experimental in vitro- and in vivo-selected mutants of Salmonella spp. suggest a counterselection of highly fluoroquinolone-resistant strains in the field. Giraud E; Brisabois A; Martel JL; Chaslus-Dancla E Antimicrob Agents Chemother; 1999 Sep; 43(9):2131-7. PubMed ID: 10471553 [TBL] [Abstract][Full Text] [Related]
18. Mutations in the gyrA and gyrB genes of fluoroquinolone-resistant Mycobacterium tuberculosis from TB patients in Thailand. Pitaksajjakul P; Wongwit W; Punprasit W; Eampokalap B; Peacock S; Ramasoota P Southeast Asian J Trop Med Public Health; 2005; 36 Suppl 4():228-37. PubMed ID: 16438215 [TBL] [Abstract][Full Text] [Related]
19. Double mutation in DNA gyrase confers moxifloxacin resistance and decreased fitness of Mycobacterium smegmatis. Luo T; Yuan J; Peng X; Yang G; Mi Y; Sun C; Wang C; Zhang C; Bao L J Antimicrob Chemother; 2017 Jul; 72(7):1893-1900. PubMed ID: 28387828 [TBL] [Abstract][Full Text] [Related]
20. In vitro selection of fluoroquinolone-resistant Neisseria gonorrhoeae harboring alterations in DNA gyrase and topoisomerase IV. Yasuda M; Fukuda H; Yokoi S; Ishihara S; Kawada Y; Deguchi T J Urol; 2000 Sep; 164(3 Pt 1):847-51. PubMed ID: 10953166 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]